The Russian Direct Investment Fund (RDIF) has reported that the nCovid-19 vaccine Sputnik V and the single-dose Sputnik Light booster nvaccine demonstrated effectiveness against the Omicron variant of the nSARS-CoV-2 virus in a study.
MANILA (Reuters) - Russia’s Gamaleya Research Institute has applied to the Philippine health regulator for emergency use authorisation of its COVID-19 vaccine but needs to file further documentation, the regulator said late Friday.